Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,036.01 +17.62 (+0.35%) Dow
38,074.12 +170.83 (+0.45%) Nasdaq
15,715.75 +110.27 (+0.71%) Bitcoin USD
59,289.04 +2,197.79 (+3.85%) CMC Crypto 200
1,275.96 +5.22 (+0.41%)
Duopharma Biotech Berhad (7148.KL)
Kuala Lumpur - Kuala Lumpur Delayed price. Currency in MYR
Add to watchlist
At close: 04:53PM MYT
Currency in MYR
Valuation measures4
| Market cap (intra-day) | 1.14B |
| Enterprise value | 1.41B |
| Trailing P/E | 21.49 |
| Forward P/E | 16.16 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.60 |
| Price/book (mrq) | 1.65 |
| Enterprise value/revenue | 2.01 |
| Enterprise value/EBITDA | 11.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.60 |
| 52-week change 3 | -19.18% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 1.5300 |
| 52-week low 3 | 1.1100 |
| 50-day moving average 3 | 1.1928 |
| 200-day moving average 3 | 1.2228 |
Share statistics
| Avg vol (3-month) 3 | 335.77k |
| Avg vol (10-day) 3 | 355.74k |
| Shares outstanding 5 | 961.94M |
| Implied shares outstanding 6 | 961.94M |
| Float 8 | 454.58M |
| % held by insiders 1 | 2.03% |
| % held by institutions 1 | 63.14% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.02 |
| Forward annual dividend yield 4 | 1.95% |
| Trailing annual dividend rate 3 | 0.02 |
| Trailing annual dividend yield 3 | 1.95% |
| 5-year average dividend yield 4 | 2.32 |
| Payout ratio 4 | 41.89% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 07 Mar 2024 |
| Last split factor 2 | 4:3 |
| Last split date 3 | 06 Sept 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 7.47% |
| Operating margin (ttm) | 6.58% |
Management effectiveness
| Return on assets (ttm) | 3.83% |
| Return on equity (ttm) | 7.84% |
Income statement
| Revenue (ttm) | 704.73M |
| Revenue per share (ttm) | 0.74 |
| Quarterly revenue growth (yoy) | 10.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 114.04M |
| Net income avi to common (ttm) | 52.65M |
| Diluted EPS (ttm) | 0.0500 |
| Quarterly earnings growth (yoy) | -50.50% |
Balance sheet
| Total cash (mrq) | 270.5M |
| Total cash per share (mrq) | 0.28 |
| Total debt (mrq) | 548.85M |
| Total debt/equity (mrq) | 79.88% |
| Current ratio (mrq) | 4.06 |
| Book value per share (mrq) | 0.71 |
Cash flow statement
| Operating cash flow (ttm) | 48.8M |
| Levered free cash flow (ttm) | -10.33M |
© 2024 Yahoo. All rights reserved.